|
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From January 1St, 2026 To Usually December 31St, 2027. Active Ingredient Amlodipine; Atc Code C08ca01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Apremilast; Atc Code L04aa32; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Golimumab; Atc Code L04ab06; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Bimekizumab; Atc Code L04ac21; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Calcium Carbonate, Colecalciferol; Atc Code A12ax (Who), A12ax01 (Adv); Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Certolizumab Pegol; Atc Code L04ab05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Dimethyl Fumarate; Atc Code D05bx02; Dosage Form Tmr; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Dexamethasone; Atc Code S01ba01; Dosage Form Imp (Implant); Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Follitropin Alfa; Atc Code G03ga05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Guanfacine; Atc Code C02ac02 (Who) N06ba21; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lebrikizumab; Atc Code D11ah10; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Tiratricol; Atc Code H03aa04; Dosage Form Tse; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Tildrakizumab; Atc Code L04ac17; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Carbamazepine; Atc Code N03af01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Carvedilol; Atc Code C07ag02; Dosage Form Fta, Tab; Potency 50 Mg (N1) 3.125 Mg (N2); Pack Size See Potency (Excluding Hospital Packs),Active Ingredient Cyproterone; Atc Code G03ha01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Darunavir; Atc Code J05ae10; Dosage Form Sue, Fta; Potency Sue (All), Fta 75 Mg (480 St), 150 Mg (240 St), 800 Mg (60 St); Pack Size See Potency (Excluding Hospital Packs),Active Ingredient Diclofenac; Atc Code M01ab05; Dosage Form Bta, Fta, Hkm, Hkp, Kmp, Tab, Tmr, Trt, Tse, Uta, Wka As Well As Rek, Ret And Sup; Potency For Bta, Fta, Hkm, Hkp, Kmp, Tab, Tmr, Trt, Tse, Uta, Wka (69.82 Mg (N1, N2, N3)), As Well As For Rek, Ret (75 Mg (N1, N2, N3)), As Well As For Sup (50 Mg (N1, N3) And 100 Mg (N1, N2, N3)); Pack Size See Potency (Excluding Hospital Packs),Active Ingredient Dexamethasone; Atc Code S01ba01; Dosage Form Atr; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Doxazosin; Atc Code C02ca04; Dosage Form Ret; Potency 8 Mg; Pack Size N1, N3 (Excluding Clinical Packs),Active Ingredient Fluconazole; Atc Code J02ac01; Dosage Form Tab, Inf; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Formoterol And Budesonide; Atc Code R03ak07; Dosage Form Ihp; Potency 194 -- 5.5 Μg (N1, N2) 380 -- 11 Μg (N2); Pack Size See Potency (Excluding Hospital Packs),Active Ingredient Glimepiride; Atc Code A10bb12; Dosage Form All; Potency 4 Mg, 6 Mg; Pack Size 60 St (Without Clinic Packs),Active Ingredient Ibuprofen; Atc Code M01ae01; Dosage Form Rek, Ret; Potency 800 Mg; Pack Size N1, N2, N3 (Exc
|
